FORBEARANCE AGREEMENT AND MODIFICATION NO. 4 TO LOAN AND SECURITY AGREEMENTForbearance Agreement and Modification to Loan and Security Agreement • January 16th, 2019 • Cancer Genetics, Inc • Services-medical laboratories
Contract Type FiledJanuary 16th, 2019 Company IndustryThis FORBEARANCE AGREEMENT AND MODIFICATION NO. 4 TO LOAN AND SECURITY AGREEMENT (this “Agreement”) is made and entered into as of January 16, 2019, by and among PARTNERS FOR GROWTH IV, L.P., a Delaware limited partnership (“PFG”), as lender, and each of (i) CANCER GENETICS, INC., a Delaware corporation (“Parent”), (ii) GENTRIS, LLC, a Delaware limited liability company (“Delaware Subsidiary”), (iii) VIVOPHARM, LLC, a Delaware limited liability company (“Vivo”), and (iv) RDDT A VIVOPHARM COMPANY PTY LTD, a company incorporated under the laws of Australia (“Australian Borrower”, and together with Parent, Delaware Subsidiary and Vivo, jointly and severally, individually and separately, “Borrower”).